Cancer cell killing by target antigen engagement with engineered complementary intracellular antibody single domains fused to pro-caspase3

<p>Many tumour causing proteins, such as those expressed after chromosomal translocations or from point mutations, are intracellular and are not enzymes <em>per se</em> amenable to conventional drug targeting. We previously demonstrated an approach (<u>A</u>ntibody-anti...

詳細記述

書誌詳細
主要な著者: Chambers, J, Brend, T, Rabbitts, T
フォーマット: Journal article
言語:English
出版事項: Nature Research 2019

類似資料